Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-24 @ 11:13 PM
Ignite Modification Date:
2025-12-25 @ 8:47 PM
NCT ID:
NCT03541369
Pre Assignment Details:
Participants were enrolled into first-in-human (FIH) groups with no step dosing (cohorts 1 - 7a), and with step dosing (cohorts 7b - 13), into extended intravenous (eIV) groups (cohorts 14 -15), and into an etanercept substudy (cohorts 16 - 17). Dosing was from Dose A (lowest) to Dose M (highest).
Recruitment Details:
Participants were enrolled at 11 study centers in 5 countries, including Australia, Canada, Germany, Japan, and the United States, and participated from 14 September 2018 to 21 February 2023.
Study:
NCT03541369
Study Brief:
Results Section:
NCT03541369